Welcome to our dedicated page for Viemed Healthcare news (Ticker: VMD), a resource for investors and traders seeking the latest updates and insights on Viemed Healthcare stock.
Viemed Healthcare, Inc. provides technology-enabled, home-based healthcare solutions and chronic disease management in the United States. Company news centers on home medical equipment and post-acute healthcare services, including respiratory care, non-invasive ventilation, sleep and resupply offerings, oxygen therapy, chronic care, and women's health products and services delivered with clinical support in the home.
Recurring updates include quarterly and annual financial results, guidance, revenue mix, patient-start trends, capital expenditure expectations, share repurchase activity, investor presentations, and analyst coverage. Viemed's releases also discuss service-line diversification, medical equipment rental, sales and supply revenue, reimbursement and coverage documentation dynamics, and the contribution of its 2025 acquisition of Lehan's Medical Equipment.
Viemed Healthcare (NASDAQ:VMD) announced details for its Second Quarter 2026 earnings conference call. The call is scheduled for Tuesday, August 4, 2026, at 11:00 a.m. EDT. Investors and interested parties in the U.S. can join by dialing 877-407-6176, while international participants can dial +1 201-689-8451.
A live audio webcast will be accessible at https://event.choruscall.com/mediaframe/webcast.html?webcastid=peVp8cbE, and a replay will be made available afterward in the Investor Relations section of www.viemed.com. Viemed provides home medical equipment and post-acute healthcare services in the U.S., focusing on respiratory, chronic care, and women's health through technology-enabled, home-based clinical support.
Viemed (NASDAQ:VMD) reported Q1 2026 results for the quarter ended March 31, 2026. Net revenue was $75.4 million, up 28% year‑over‑year. Net income attributable totaled $2.6 million, and Adjusted EBITDA was $14.3 million, a 12% increase.
The company repurchased 150,000 shares for $1.4 million, held $9.8 million in cash, and updated full‑year 2026 guidance: net revenue $312–$320M, Adjusted EBITDA $65–$69M, and net capex 9%–10.5% of revenue.
Viemed Healthcare (NASDAQ:VMD) will host its First Quarter 2026 earnings conference call on Wednesday, May 6, 2026 at 11:00 a.m. EDT. Interested parties may dial provided numbers or listen via live webcast; a replay will be posted in the Investor Relations section at www.viemed.com.
Viemed Healthcare (NASDAQ:VMD) will present and host one-on-one investor meetings at Sidoti's Small-Cap Virtual Investor Conference on March 18-19, 2026. The company presentation is scheduled for 1:45 p.m. ET on March 19, 2026. Registration is free and open online.
Investors can access the live presentation via Sidoti's webinar link and sign up for virtual one-on-ones on March 18-19, 2026.
Viemed Healthcare (NASDAQ:VMD) reported record 2025 results and issued 2026 guidance on March 4, 2026. Q4 net revenue was $76.2M (+26% YoY) and FY revenue was $270.3M (+21% YoY). FY net income was $14.9M ($0.37/diluted), Adjusted EBITDA a record $61.4M.
The company generated $51.9M cash from operations and $28.1M free cash flow in 2025, maintained $13.5M cash and $7.4M working capital, and had $46M available on its credit facility. 2026 guidance: revenue $310–320M, Adjusted EBITDA $65–69M, capex 10–11.5% of revenue. Board authorized a 2026 share repurchase program.
Viemed Healthcare (NASDAQ:VMD) announced a share repurchase program effective through March 2027 authorizing purchases of up to 1,930,131 common shares, about 5% of issued shares as of March 4, 2026. Purchases may occur via open market or block trades and repurchased shares will be cancelled.
The company highlighted prior repurchases of ~4.5 million shares totaling $26.3 million, record 2025 revenue and Adjusted EBITDA, more than doubled free cash flow year-over-year, $13.5 million cash at year-end, and effectively no net debt.
Viemed Healthcare (NASDAQ:VMD) will host its Year End 2025 earnings conference call on Thursday, March 5, 2026 at 11:00 a.m. ET. Interested parties may dial US Toll-Free or international numbers or join via live audio webcast.
A replay will be available in the Investor Relations section of the company website at www.viemed.com after the live call.
Viemed Healthcare (NASDAQ:VMD) reported third quarter 2025 results for the three and nine months ended September 30, 2025. Q3 net revenue reached a company record of $71.9M, up 24.0% year-over-year. Net income for Q3 was $3.5M or $0.09 per diluted share. Adjusted EBITDA totaled $16.1M, a 15.5% increase versus prior year.
Cash flow: operating cash flow was $18.4M for the quarter and $48.5M TTM; free cash flow was $12.4M for the quarter and $23.3M TTM.
Corporate actions: closed acquisition of Lehan's Medical Equipment on July 1, 2025; repurchased 1,706,380 shares for $11.4M. Balance sheet: cash $11.1M, working capital $5.8M, long-term debt $19.6M. 2025 guidance updated to $271M–$273M revenue and $60M–$62M adjusted EBITDA.
Viemed Healthcare (NASDAQ:VMD) will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025 at 11:00 a.m. ET. Participants can join by phone at (877) 407-6176 (US toll-free) or +1 (201) 689-8451 (international), or via live audio webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC. A replay will be available in the Investor Relations section of Viemed's website at https://www.viemed.com. The call covers Viemed's Q3 2025 results and related commentary for investors and analysts.
Viemed Healthcare (NASDAQ: VMD) will present at the LD Micro Main Event XIX on Tuesday, October 21, 2025 at 11:00 AM PT at Hotel del Coronado in San Diego. Trae Fitzgerald, chief financial officer, will cover operational priorities, financial performance, and strategic direction. Management will be available for one-on-one investor meetings during the three-day conference.
The Main Event runs October 19–21, 2025, features roughly 120 companies presenting in half-hour slots, and includes keynotes, private investor meetings, and a closing reception. Investors can register to watch Viemed's virtual presentation.